For example, if a firm that knew almost nothing about water infrastructure was asked to build a wastewater treatment plant, their success – the project’s success – would be a matter of abstracting processes, thinking systematically and schematically, and asking questions – not accepting the status quo.
Complicated supply chain.Pharmaceutical manufacturing of a single product through its lifecycle spans multiple functions and sites within each organisation and spans multiple organisations through product acquisitions and contract manufacturing.
Thus, the breadth of what needs to be changed to deploy a new platform technology is significant.. Resistance to challenging accepted practice.Regulatory and patient safety risks are always high up the agenda for the pharmaceutical industry.The unfamiliar and the new are assessed as having higher risk than the known.. How manufacturing sits versus perceived value creation in the pharmaceutical companies.
In reality, pharmaceutical value creation comes from the development or acquisition of promising NCEs, and their ability to commercialise them.Manufacturing is complicated and costly and may be seen as a necessary inconvenience, rather than a potential strategic advantage..
The locus of power and decision-making in companies.
Operational engineering and manufacturing drive the majority of investment plans and proposals.There is a conversation about contracts like the integrated form of agreement developed by.
(Chief of Staff & EVP at Boldt Construction) and how this illustrates the move towards shared risk and reward, encouraging all parties to work together towards a common goal.. 3.The role of standardisation and modularisation:.
The discussion points out the tension between the desire for bespoke designs and the benefits of standardisation and modularisation in construction.By standardising certain elements, like in the apparel industry, there's potential for increased creativity and efficiency.
(Editor: All-in-One Organizers)